CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 95 of 652
Non-Antibody Products
Page 95 of 652
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| 246C10 | An ionizable cationic lipid (pKa = 6.75); has been used in combination wit… | 25 mg | 37907-25 | More Info |
| 246C10 | An ionizable cationic lipid (pKa = 6.75); has been used in combination wit… | 5 mg | 37907-5 | More Info |
| 680C91 | A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… | 10 mg | 34823-10 | More Info |
| 680C91 | A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… | 25 mg | 34823-25 | More Info |
| 680C91 | A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… | 5 mg | 34823-5 | More Info |
| 680C91 | A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… | 50 mg | 34823-50 | More Info |
| C-02 | A PROTAC that drives hexokinase 2 degradation; induces degradation of hexo… | 1 mg | 39384-1 | More Info |
| C-02 | A PROTAC that drives hexokinase 2 degradation; induces degradation of hexo… | 5 mg | 39384-5 | More Info |
| C-02 | A PROTAC that drives hexokinase 2 degradation; induces degradation of hexo… | 500 µg | 39384-500 | More Info |
| C12-113 | An ionizable cationic lipidoid; has been used in combination with other li… | 10 mg | 39335-10 | More Info |
| C12-113 | An ionizable cationic lipidoid; has been used in combination with other li… | 25 mg | 39335-25 | More Info |
| C12-113 | An ionizable cationic lipidoid; has been used in combination with other li… | 5 mg | 39335-5 | More Info |
| C12-200 | A branched-chain ionizable cationic lipidoid; has been used in combination… | 10 mg | 36699-10 | More Info |
| C12-200 | A branched-chain ionizable cationic lipidoid; has been used in combination… | 100 mg | 36699-100 | More Info |
| C12-200 | A branched-chain ionizable cationic lipidoid; has been used in combination… | 25 mg | 36699-25 | More Info |
| C12-200 | A branched-chain ionizable cationic lipidoid; has been used in combination… | 50 mg | 36699-50 | More Info |
| C14-4 | An ionizable cationic lipid; has been used in the generation of lipid nano… | 1 mg | 38942-1 | More Info |
| C14-4 | An ionizable cationic lipid; has been used in the generation of lipid nano… | 10 mg | 38942-10 | More Info |
| C14-4 | An ionizable cationic lipid; has been used in the generation of lipid nano… | 5 mg | 38942-5 | More Info |
| C-170 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 10 mg | 30157-10 | More Info |
| C-170 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 100 mg | 30157-100 | More Info |
| C-170 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 25 mg | 30157-25 | More Info |
| C-170 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 50 mg | 30157-50 | More Info |
| C-171 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 10 mg | 30159-10 | More Info |
| C-171 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 100 mg | 30159-100 | More Info |
| C-171 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 25 mg | 30159-25 | More Info |
| C-171 | A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… | 50 mg | 30159-50 | More Info |
| C-176 | A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… | 10 mg | 25859-10 | More Info |
| C-176 | A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… | 100 mg | 25859-100 | More Info |
| C-176 | A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… | 25 mg | 25859-25 | More Info |
| C-176 | A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… | 50 mg | 25859-50 | More Info |
| C-178 | A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… | 10 mg | 25860-10 | More Info |
| C-178 | A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… | 25 mg | 25860-25 | More Info |
| C-178 | A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… | 5 mg | 25860-5 | More Info |
| C-178 | A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… | 50 mg | 25860-50 | More Info |
| C18 | A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… | 1 mg | 39432-1 | More Info |
| C18 | A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… | 10 mg | 39432-10 | More Info |
| C18 | A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… | 25 mg | 39432-25 | More Info |
| C18 | A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… | 5 mg | 39432-5 | More Info |
| C188-9 | A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… | 10 mg | 30928-10 | More Info |
| C188-9 | A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… | 25 mg | 30928-25 | More Info |
| C188-9 | A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… | 5 mg | 30928-5 | More Info |
| C188-9 | A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… | 50 mg | 30928-50 | More Info |
| C25-140 | An inhibitor of the TRAF6-Ubc13 protein-protein interaction (IC50 = 2.6 &m… | 1 mg | 39669-1 | More Info |
| C25-140 | An inhibitor of the TRAF6-Ubc13 protein-protein interaction (IC50 = 2.6 &m… | 10 mg | 39669-10 | More Info |
| C25-140 | An inhibitor of the TRAF6-Ubc13 protein-protein interaction (IC50 = 2.6 &m… | 25 mg | 39669-25 | More Info |
| C25-140 | An inhibitor of the TRAF6-Ubc13 protein-protein interaction (IC50 = 2.6 &m… | 5 mg | 39669-5 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 1 mg | 21177-1 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 10 mg | 21177-10 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 25 mg | 21177-25 | More Info |
| C2-8 | An inhibitor of polyQ aggregation (IC50s = 25 and 0.05 µM for recomb… | 5 mg | 21177-5 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 1 mg | 27029-1 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 10 mg | 27029-10 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 25 mg | 27029-25 | More Info |
| C29 | An inhibitor of TLR2 signaling; inhibits synthetic and bacterial TLR2 agon… | 5 mg | 27029-5 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 1 mg | 33166-1 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 10 mg | 33166-10 | More Info |
| C3 | An inhibitor of MAO-B (IC50 = 0.021 µM); selective for MAO-B over MA… | 5 mg | 33166-5 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 10 mg | 21771-10 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 25 mg | 21771-25 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 5 mg | 21771-5 | More Info |
| C527 | An inhibitor of the USP1 / UAF complex; inhibits USP1 / UAF deubiquitinase… | 50 mg | 21771-50 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 1 mg | 37354-1 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 10 mg | 37354-10 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 5 mg | 37354-5 | More Info |
| C53 | A STING agonist; activates human wild-type STING (EC50 = 185 nM), as well… | 50 mg | 37354-50 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 1 mg | 10549-1 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 10 mg | 10549-10 | More Info |
| C646 | An inhibitor of the HAT p300 (IC50 = 1.6 µM); competitively binds p3… | 5 mg | 10549-5 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 1 g | 21601-1 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 100 mg | 21601-100 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 250 mg | 21601-250 | More Info |
| C-7280948 | A PRMT1 inhibitor (IC50 = 12.8 µM, in vitro) | 500 mg | 21601-500 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 1 mg | 33563-1 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 10 mg | 33563-10 | More Info |
| C82 | An Mtb CdnP inhibitor (IC50 = 17.5 µM); selective for Mtb CdnP over… | 5 mg | 33563-5 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 10 mg | 36578-10 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 25 mg | 36578-25 | More Info |
| C-87 | An inhibitor of TNF-α; binds to TNF-α; inhibits TNF-α-in… | 5 mg | 36578-5 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 10 mg | 40863-10 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 25 mg | 40863-25 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 5 mg | 40863-5 | More Info |
| C10-200 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 50 mg | 40863-50 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 1 mg | 31064-1 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 10 mg | 31064-10 | More Info |
| C3001a | An activator of K2P2.1 / TREK1 and K2P10.1 / TREK2; increases current ampl… | 5 mg | 31064-5 | More Info |
| CA-074 | A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… | 1 mg | 24679-1 | More Info |
| CA-074 | A selective cathepsin B inhibitor (Kis = 0.0087, 75, and 233 µM for… | 500 µg | 24679-500 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 1 mg | 27598-1 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 10 mg | 27598-10 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 25 mg | 27598-25 | More Info |
| CA-4948 | An orally bioavailable inhibitor IRAK-4; has antitumor activity in ABC-typ… | 5 mg | 27598-5 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 1 mg | 37300-1 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 10 mg | 37300-10 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 25 mg | 37300-25 | More Info |
| CA77.1 | An inducer of chaperone-mediated autophagy; induces the formation of autop… | 5 mg | 37300-5 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 1 mg | 40256-1 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 10 mg | 40256-10 | More Info |
| C14-A1 | An ionizable cationic lipid; has been used in the generation of LNPs; LNPs… | 5 mg | 40256-5 | More Info |
| Cabazitaxel | A semisynthetic taxane; stabilizes microtubule assembly by reducing lag ti… | 10 mg | 22262-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile